CEO Stock Watch: Healthcare Realty Trust Inc, General Growth Properties Inc, Mylan Laboratories, Inc., Dividend Capital Trust, Inc.

Author's Avatar
Jun 22, 2007
Highlights on recent CEO stock purchases. Healthcare Realty Trust (HR, Financial), General Growth Properties, Inc. (GGP, Financial), Mylan Laboratories, Inc. (MYL, Financial), Dividend Capital Trust, Inc. (DCT, Financial)


Healthcare Realty Trust (HR)


Chairman and CEO of Healthcare Realty Trust (HR), David R Emery, bought 23,300 shares of HR stock on 06/20/2007 at the average price of $28.84. Healthcare Realty Trust Incorporated, a real estate investment trust, engages in the ownership, acquisition, management, and development of real estate properties associated with the delivery of healthcare services in the United States. Healthcare Realty Trust Inc. has a market cap of $1.39 billion, it was traded at around $28.77 with P/E ratio of 21.68 and P/S ratio of 5.21.


General Growth Properties, Inc. (GGP)


General Growth Properties, Inc. (GGP) CEO John Bucksbaum bought 20,000 shares of GGP stock on 06/19/2007 at the average price of $54.38. After the purchase he owns 634,625 of GGP. General Growth Properties, Inc. operates as a self-administered and self-managed real estate investment trust. The company operates through two segments, Retail and Other, and Master Planned Communities. General Growth Properties Inc. has a market cap of $12.96 billion, it was traded at around $52.89 with P/E ratio of 48.14 and P/S ratio of 4.11.


General Growth Properties, Inc. (GGP) is also bought by its CFO and directors. CFO Bernard Freibaum bought 35,000 shares of GGP stock on 06/08/2007 at the average price of $55. He has been buying since February as prices of GGP went down. Since then he bought 655,000 shares. He owns 7,301,137 after these purchases. Director Adam S Metz bought 5,000 shares of GGP stock on 05/24/2007 at the average price of $56.5; on 05/17/2007 he bought 20,000 shares at the average price of 59.07.


Gurus’ Takes: General Growth Properties Inc. is owned by 3 Gurus. Chris Davis owns 16,912,278 shares as of 03/31/2007, an increase of 4.22% of from the previous quarter. This position accounts for 1.19% of the $91.56 billion portfolio of Davis Selected Advisers. Ron Baron owns 505,300 shares as of 03/31/2007, an increase of 0.16% of from the previous quarter. This position accounts for 0.18% of the $17.98 billion portfolio of Baron Funds.


Mylan Laboratories, Inc. (MYL)


Mylan Laboratories, Inc. Vice Chairman, CEO Robert J Coury bought 20,000 shares of MYL stock on 06/15/2007 at the average price of $18.59. He also bought 30,000 more shares of MYL stock at the average price of 18.54 in June, the price of the stock has increased by 1.35% since.


Dividend Capital Trust, Inc. (DCT)


Dividend Capital Trust, Inc. CEO Philip L Hawkins bought 5,000 shares of DCT stock on 06/13/2007 at the average price of $10.24, the price of the stock has increased by 6.05% since. Dividend Capital Trust, Inc. is a publicly owned real estate investment trust. The firm provides its services to companies. Through its fund, it engages in the ownership, operation, and development of real estate properties. DCT INDUSTRIAL TRUST has a market cap of $1.83 billion, it was traded at around $10.86 with P/S ratio of 7.63.


CFO Stuart B Brown bought 2,350 shares of DCT stock on 06/07/2007 at the average price of $10.46, the price of the stock has increased by 3.82% since; also on 05/11/2007Stuart B Brown bought 2,270 shares of DCT stock at the average price of $10.8, the price of the stock has increased by 0.56% since.


Gurus’ Takes: Chris Davis owns 3,590,085 shares as of 03/31/2007, an increase of 6.84% of from the previous quarter. This position accounts for 0.05% of the $91.56 billion portfolio of Davis Selected Advisers.